Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Corneal Melting”

6 trials

Showing 6 of 6 results

Very early researchStudy completedNCT02168790
What this trial is testing

Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access)

Who this might be right for
Corneal UlcersCorneal Melting
Klinikum Chemnitz gGmbH 7
Not applicableLooking for participantsNCT03041883
What this trial is testing

Corneal Collagen Crosslinking to Increase the Resistance of the Support Graft of the KPro Type I Against Corneal Melting

Who this might be right for
Corneal Melting in Boston Keratoprosthesis Type I
Centre hospitalier de l'Université de Montréal (CHUM) 40
Early research (Phase 1)Looking for participantsNCT02987686
What this trial is testing

Topical Infliximab for Sterile Corneal Melt

Who this might be right for
Sterile Corneal Melt
Centre hospitalier de l'Université de Montréal (CHUM) 12
Not applicableNot Yet RecruitingNCT07440186
What this trial is testing

Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiologics) in the Treatment of Corneal Melting (RCJ-COL3D-MC-01-2026)

Who this might be right for
Patients With Severe Corneal Melting
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 4
Testing effectiveness (Phase 2)Study completedNCT02863809
What this trial is testing

Vision Restoration With a Collagen Crosslinked Boston Keratoprosthesis Unit

Who this might be right for
Keratolysis
Joseph B. Ciolino, MD 76
Testing effectiveness (Phase 2)WithdrawnNCT02126020
What this trial is testing

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Who this might be right for
Stevens-Johnson SyndromeToxic Epidermal Necrolysis (Lyell) SyndromeMucous Membrane Pemphigoid
James Chodosh, MD, MPH

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation